Found 183 results in Expert Content

Hear from a panel of experts on the critical challenges of spray dried powder formulation development, risk mitigation strategies and more.

Summary: In this webinar, experts will explore the journey from molecule candidate selection to first-in-human clinical studies, discussing the process from initial formulation conception to forming accelerated pathways to clinical trials.

Summary: Join this webcast to hear a panel of drug developers discuss how innovative trial designs, on-demand manufacturing, real-time clinical data-based dose adjustments and partnering with experienced formulators and Contract Research Organizations (CROs) can enable faster, better decision making during phase 1 clinical trials.

Summary: In this exclusive webinar designed for drug developers and pharmaceutical and biotechnology consultants, experts review the importance of the Target Product Profile (TPP).

Summary: Insights into the spray drying process and learn how a robust scale-up methodology can be used to progress spray dry formulations from pilot scale to commercial scale production.

Summary: A panel of drug developers discuss innovative trial designs, on-demand manufacturing, communicating between clinical partners, prepping a strong regulatory submission and enabling faster decision making in your phase I trial.

Summary: Download this executive summary article to learn about best practices and strategies to mitigate risks and ensure a successful tech transfer from development through to commercial scale spray drying of pharmaceutical products.

Summary: Download this executive summary to learn more about safe and successful HPAPI product development and manufacturing using micronization.

Summary: As drug developers look to address unmet medical needs for orphan diseases, working with experienced partners can help in navigating key challenges such as a limited active pharmaceutical ingredient supply, efficient small-scale manufacturing for small patient populations and distribution logistics

Summary: Decisions made throughout early and mid-stage clinical trials impact late-stage results and sometimes, entire programs and companies. Since some obstacles can prove overwhelming for startups, there is a lot to learn from those who successfully walked the path.